KU Hem/Onc. Formerly Hem/Onc Fellow @DukeMedicine. @ClevelandClinic Internal Medicine Resident. Passionate about #MedEd, breast cancer, politics and theatre.
@thriftycars at SFO. 2 hour line to get to the check-in desk to be told they didn’t have a car available right now. Have to wait another 45-60 minutes, already been another hour. Is it reasonable to be waiting 3+ hours for a rental car? Because I don’t think so.
One of the true treats of in-person conferences is seeing blasts from the past. @NAbuhadra is one of the kindest, hilarious and engaging people. It doesn’t hurt that she’s a brilliant breast oncologist at MSKCC! Thrilled to reconnect, Nour! #ASCO22
@hoperugo discusses Tropics02
Sacituzumab versus Physician Choice chemotherapy in heavily pretreated HR+/HER2- BC.
PFS 5.5 v 4.0 m (HR 0.66)
OS immature
A positive study. Biomarker needed. Trop2 level analysis will be interesting.
#bcsm#ASCO2022@OncoAlert
📣 Heme Onc Fellows searching for jobs in academia, see👇🏼! Sign up to meet with outstanding early career faculty & get invaluable guidance on the job search! Retweet to share w/other fellows! #ASCO22@dr_simkins@RyanRaderMD@YuWeiChenMD@MadisonConces@LoganRoofMD @KunalDesaiMD
Management of the Top 10 Most Common Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy #cancer@oncoalert https://t.co/W5nlbPRShb @ASCO@JCOOP_ASCO
What a ride! Four intense days of presentations, discussions, insights & networking. @SABCSSanAntonio never disappoints.
Here’s my 5 take-home messages from these days.
As usual, these are not exhaustive, as #SABCS21 was truly full of amazing science and striking advancements.
Studies have shown lower risks of GI bleeding on apixaban when compared to rivaroxaban. CVS Caremark is planning to take apixaban off formulary and out of the hands of patients. We should not give patients fewer options. (No conflicts of interest)
NBCA has learned the largest pharmacy benefits manager (PBM) in the U.S., CVS Caremark, has made changes to their 2022 commercial formulary which will reduce anticoagulant choices for patients. Learn about what NBCA is doing to advocate for patients: https://t.co/DaQDZRrF3A
SOFT and TEXT 12-13 yr med FU confirms benefit of EXE+OFS in high risk HER2 neg HR+ BC in premen women. 10% benefit in survival in. <35yo with T/OFS v T and 15% with E/OFS @OncoAlert
She was a senior, he was an intern… and the rest is history. Another CCF power-couple got married this weekend! 👰🏻♀️🤵🏼From the wards to the altar, married by one of ours @danielmarcosmd; CCF family celebration! 🍾@BryceMontane @RyanRaderMD@ErinCovert22@J_YoonYoon
More than 99.99% of fully vaccinated people have not had a breakthrough case of Covid-19 resulting in hospitalization or death, a CNN analysis shows https://t.co/AukcsIjVwq
Affordable Care Act and Cancer Survivors' Financial barriers in cancer survivors age 18-64 years significantly improved following ACA implementation https://t.co/TyaGu74NVe @ASCO_pubs@ASCO@OncoAlert